Sponsor:
W.L.Gore & Associates
Code:
NCT07390344
Conditions
Ascites
Variceal Bleeding
Portal Hypertension Related to Cirrhosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion (6-10mm)
Brief summary:
Conditions
Ascites
Variceal Bleeding
Portal Hypertension Related to Cirrhosis
Study ID
NCT07390344
Start date
Jul 20, 2026
Status verified date
Oct, 2026
Completion date
Sep 30, 2029
Anticipated
Primary completion date
Sep 30, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
152 participants
Anticipated
Arms
Subjects treated for portal hypertension with the Registry device
Interventions
GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion (6-10mm)
Primary outcome measure
Central contacts
Locations
Emory University Hospital
Recruiting
Atlanta, Georgia, United States, 30322
Contacts
Principal Investigator:
Bryan Nicholas Swilley, MD
University of Minnesota
Recruiting
Minneapolis, Minnesota, United States, 55455
Contacts
Reza Talaie, MD
rtalaie@umn.eduPrincipal Investigator:
Reza Talaie, MD
Cleveland Clinic
Recruiting
Cleveland, Ohio, United States, 44195
Contacts
Principal Investigator:
Sameer Gadani, MD
Sponsor
W.L.Gore & Associates
Last update posted
Oct 5, 2026
Last verified
Oct, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-08. This information was provided to ClinicalTrials.gov by W.L.Gore & Associates on 2026-10-05. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.